ELIQUIS® (apixaban) dosing | patients with renal or hepatic impairment | ELIQUIS UK
Eliquis (Apixaban Tablets): Uses, Dosage, Side Effects, Interactions, Warning
Full article: Bleeding risk of apixaban, dabigatran, and low-dose rivaroxaban compared with warfarin in Japanese patients with non-valvular atrial fibrillation: a propensity matched analysis of administrative claims data
ELIQUIS® (apixaban) dosing | patients with renal or hepatic impairment | ELIQUIS UK
Sensitivity analyses of apixaban dose and bleeding | Download Table
Dosing and Administration | ANDEXXA | For HCPs
Health Canada dosing algorithm for apixaban according to renal... | Download Scientific Diagram
apixaban - General Practice notebook
Peripheral Matters | Dose-Reduced Direct Oral Anticoagulants: Practical Considerations - American College of Cardiology
Anticoagulant Therapy – Options, Dosing and Risks
Eliquis (apixaban): Side effects, dosage, uses, and more
ELIQUIS® (apixaban) dosing for DVT & PE patients | ELIQUIS UK
Apixaban concentration variability and relation to clinical outcomes in real-life patients with atrial fibrillation | Scientific Reports
Apixaban : Low Dose of Warfarin Alternative May Prevent Stroke in Dialysis Patients
Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial - ScienceDirect
DVT Prophylaxis After Hip/Knee Surgery|ELIQUIS® (apixaban) Safety Info
Apixaban - Uses | Dosage | Side Effects | Drug Warnings | and Precautions
Indication and dose regimens of Dabigatran etexilate, Rivaroxaban, and... | Download Table
Target-Specific Oral Anticoagulants
Table 1 from Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical
Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach | PLOS ONE
Aspirin and an oral anticoagulant – can they be used together? - NPS MedicineWise
Apixaban Concentrations in Routine Clinical Care of Older Adults With Nonvalvular Atrial Fibrillation - ScienceDirect
Cureus | Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting in India: A Literature Review | Article
Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction - ScienceDirect
